Research Resources

We are continually aggregating and updating COVID-19 research resources (publications, data tools, and laboratory resources) to support your work. If you have resources that we should add, please send them to us.

General Resources

  • COVID-19 Research Guidelines and Policies
    Refer to the main Office of Research website for all guidelines and policies for safe, effective, and responsible conduct of research during the pandemic.
  • Coronavirus Method Development Community 
    An open-access repository for scientific methods and has a coronavirus method development group. 
  • COVID Research Patient and Community Advisory Board (PCAB)  
    The UCSF COVID-19 Research Patient and Community Advisory Board (PCAB) provides review and feedback for UCSF clinical and translational research directly related to COVID-19. Intense public concern about the COVID-19 pandemic and evidence of profound inequities in the pandemic’s toll on communities of color and low-income communities accentuate the importance of community engagement in the conduct of clinical research on COVID-19. The COVID-19 Research PCAB is a group of diverse experts, including patients, leaders of clinical systems, community-based organizations, civic agencies, and other community members who have a stake in the outcomes of COVID-19 research. All investigators conducting COVID-related clinical and community research are strongly encouraged to obtain a consultation from the UCSF COVID-19 PCAB. Request a COVID-19 PCAB review session by requesting a Community-Engaged Research Consultation.

Literature Resources

UCSF Library has curated a large list of resources for COVID-19 related literature. An additional resource is noted below:

Datasets & Visualization Tools

A primary, large list of clinical, epidemiological, genomic and other research data resources, curated by the UCSF Library, can be found at COVID-19 Data and Dashboards. Some additional data resources are referenced below. 

Clinical 

Communication

Epidemiology and Population Health 

Omic

Other Research 

  • DeepLesion: NIH dataset of 32,000 CT Images
    The National Institutes of Health’s Clinical Center has made a large-scale dataset of CT images publicly available to help the scientific community improve detection accuracy of lesions.
  • COVID-19: Algorithms and Clinical Guidance 
    COVID-19 patient care protocols with the latest best practices and CDC guidance  
  • BioRender Vaccine and Drug Therapeutics Tracker 
    This site offers visualized development progress and additional information on preclinical and human clinical vaccine as well as therapeutic drug candidates against SARS-CoV-2 and the associated COVID-19 disease. 
  • Drugs and Vaccine Tracker from STAT  
    Sponsored by Johnson and Johnson, this site offers a guide to some of the most talked-about efforts to treat or prevent coronavirus infection, with details on the science, history, and timeline for each endeavor.
  • UCSF BioCatalyst 
    This biobank search engine will enable UCSF to address the underutilization of biospecimens and provide researchers with a central ecosystem of all associated clinical and transomic data. 

Data Computing Resources

  • UCSF AWS COVID19
    Researchers at UCSF that wish to conduct COVID-19 related research and obtain Amazon Web Services (AWS) credits to cover the cost of the computing resources for that research can contact IT for help in planning and submitting the ask for credits. Please contact Ryan Hunt and/or reply to the survey.

Laboratory Materials

  • SARS-CoV-2 Replicon (cDNA) for Various Gene Cloning Purposes
    Contact Nevan Krogan for more information
  • Lung Organoid Model: A collection of labs are assembling a rapid-translation pathway based on organoids and lung culture systems. For information about plugging into the program/platform, please contact ImmunoX.
  • SARS-CoV-2 virus: All work with SARS-CoV-2 must be performed under Biosafety Level 3 (BSL3) containment. To work with the virus at UCSF you must have access to a BSL3 facility, and you must have an approved Biological User Authorization that describes all experimental procedures and biohazard mitigation. For more information, contact Anita Sil.